HeinOnline includes a “COVID-19: Pandemics Past and Present” database of publications, government reports, and scholarly articles. The main database sections focus on COVID-19’s Economic Impact, Health Care Impact, and Societal Impact in America, as well COVID-19’s wider Global Impact. Two …
The C|M|LAW Center for Health Law and Policy and Health Law Society launches its Speaker Series with the 1/28/2022 “COVID and Crisis Standards of Care: Medical-Legal Implications” presentation by Michael Anderson, MD, MBA, FAAP, FCCM, FAARC. Dr. Anderson will review …
Michael Anderson Talk/Webinar on COVID and Crisis Standards of Care Read more »
On 12/9/2021, the U.S. Food and Drug Administration (FDA) expanded the use of a single Pfizer-BioNTech COVID-19 Vaccine booster dose to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer …
FDA Expands Pfizer Booster Use to 16-17 Years-Old Read more »
The World Health Organization (WHO) designated the SARS-CoV-2 variant B.1.1.529, named Omicron, as a Variant of Concern (VOC) on 11/26/2021. WHO has asked countries to enhance surveillance and sequencing efforts, submit complete genome sequences and associated metadata to a publicly …
The U.S. Food and Drug Administration (FDA) recently amended the emergency use authorizations for the Pfizer-BioNTech and Moderna COVID-19 vaccines. The FDA is now authorizing use of a single booster dose for all individuals 18 years of age and older …
FDA Expands Eligibility for COVID-19 Vaccine Boosters Read more »
